JPWO2021255900A1 - - Google Patents
Info
- Publication number
- JPWO2021255900A1 JPWO2021255900A1 JP2021523527A JP2021523527A JPWO2021255900A1 JP WO2021255900 A1 JPWO2021255900 A1 JP WO2021255900A1 JP 2021523527 A JP2021523527 A JP 2021523527A JP 2021523527 A JP2021523527 A JP 2021523527A JP WO2021255900 A1 JPWO2021255900 A1 JP WO2021255900A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021130913A JP2022000635A (ja) | 2020-06-18 | 2021-08-10 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2020/023982 WO2021255900A1 (ja) | 2020-06-18 | 2020-06-18 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021130913A Division JP2022000635A (ja) | 2020-06-18 | 2021-08-10 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP6933834B1 JP6933834B1 (ja) | 2021-09-08 |
| JPWO2021255900A1 true JPWO2021255900A1 (https=) | 2021-12-23 |
Family
ID=77549998
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523527A Active JP6933834B1 (ja) | 2020-06-18 | 2020-06-18 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
| JP2021130913A Pending JP2022000635A (ja) | 2020-06-18 | 2021-08-10 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021130913A Pending JP2022000635A (ja) | 2020-06-18 | 2021-08-10 | 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20230221337A1 (https=) |
| JP (2) | JP6933834B1 (https=) |
| WO (1) | WO2021255900A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2022030629A1 (https=) * | 2020-08-07 | 2022-02-10 | ||
| WO2023007809A1 (ja) * | 2021-07-29 | 2023-02-02 | 国立大学法人東北大学 | コロナウイルス感染症の重症化リスクの評価方法、およびコロナウイルス感染症の重症化リスク評価キット |
| WO2023063021A1 (ja) * | 2021-10-11 | 2023-04-20 | 国立大学法人大阪大学 | 患者の分類方法、キットおよびバイオマーカーの使用 |
| JP7849689B2 (ja) * | 2021-12-15 | 2026-04-22 | 三洋化成工業株式会社 | 検査方法及び検査試薬 |
| JPWO2024029523A1 (https=) * | 2022-08-02 | 2024-02-08 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973470B2 (en) * | 2015-07-19 | 2021-04-13 | Sanmina Corporation | System and method for screening and prediction of severity of infection |
| JP6581273B1 (ja) * | 2018-09-28 | 2019-09-25 | シミックホールディングス株式会社 | 肝型脂肪酸結合タンパク質を定量する方法、その定量用キット、腎疾患の検査方法、その検査キット及びコンパニオン診断薬 |
| US10689716B1 (en) * | 2020-03-19 | 2020-06-23 | University Of Miami | Materials and methods for detecting coronavirus |
-
2020
- 2020-06-18 WO PCT/JP2020/023982 patent/WO2021255900A1/ja not_active Ceased
- 2020-06-18 JP JP2021523527A patent/JP6933834B1/ja active Active
- 2020-06-18 US US17/928,371 patent/US20230221337A1/en active Pending
-
2021
- 2021-08-10 JP JP2021130913A patent/JP2022000635A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021255900A1 (ja) | 2021-12-23 |
| JP2022000635A (ja) | 2022-01-04 |
| US20230221337A1 (en) | 2023-07-13 |
| JP6933834B1 (ja) | 2021-09-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210422 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210422 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210629 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210630 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210713 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210810 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6933834 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |